Advertisement
Orthopedics
Subscribe to Orthopedics
View Sample

FREE Email Newsletter

Medtronic prevails in bone mill antitrust suit filed by Lenox MacLaren Surgical

July 3, 2013 11:21 am | by Mass Device | News | Comments

Medtronic (NYSE:MDT) prevailed in an antitrust lawsuit filed over a bone mill made by Lenox MacLaren Surgical, with a federal judge ruling that Lenox misrepresented the size of the bone mill market and failed to adequately market its own device.

More hospitals settle Medtronic's Kyphon Medicare fraud cases

July 2, 2013 12:58 pm | by Mass Device | News | Comments

Some 55 U.S. hospitals agreed to pay a total of $34 million to settle U.S. Justice Dept. charges that they overcharged Medicare for Medtronic's (NYSE:MDT)'s kyphoplasty spine procedure, acquired in the $3.9 billion buyout of Kyphon in 2007, the Justice Dept. said today.

Integra LifeSciences recall affects Medtronic's Infuse kits

July 2, 2013 12:53 pm | by Mass Device | News | Comments

Minnesota medical device giant Medtronic (NYSE:MDT) confirmed today that it recalled certain of its already-troubled Infuse spinal fusion surgery kits after learning of possible contamination in sponges manufactured by Integra Lifesciences.  

Advertisement

SpineGuard Obtains Regulatory Clearance to Sell Cannulated PediGuard® in Mexico

July 2, 2013 12:00 pm | by Business Wire | News | Comments

SpineGuard announced today that it has obtained regulatory clearance from COFEPRIS (the Mexican healthcare regulatory authority) to sell its Cannulated PediGuard® device in Mexico. SpineGuard has previously received clearance for its Classic PediGuard device, and over 50 Mexican spine surgeons have been trained on the technology.

Identifying Patients Who Can Skip ACL Reconstruction

July 2, 2013 10:19 am | by Hospital for Special Surgery | News | Comments

A study by researchers at Hospital for Special Surgery has provided the first evidence that the shape of a person's knee could be a factor in the decision of whether a patient should undergo anterior cruciate ligament reconstruction after an ACL tear.

Implantable Drug Delivery Devices—An Overview

July 1, 2013 4:13 pm | by James Arps, Ph.D., Director, ProMed Pharma LLC | ProMed Molded Products, Inc. | Articles | Comments

As more therapies are able to indicate implantable devices for treatment, incorporating drug delivery into them can be a significant additional benefit. Even when drug delivery is the primary function, implantable devices can be preferable. This article reviews some representative applications that device designers can leverage in developing new products for the implantable drug delivery market.

Poland - a New Player in Medical Tourism Sector

June 28, 2013 9:00 am | by PR Newswire | News | Comments

Is it possible, that in 2-3 years Brits, Germans, Scandinavians, and Russians will undergo cancer treatment, orthopaedic, or cardiac surgery procedures in Polish medical facilities more often? Treat teeth and get implants in dental clinics; take a cure in Polish sanatoriums?

Spinning Up Antibacterial Silver on Glass

June 27, 2013 10:30 am | by Inderscience Publishers | News | Comments

The antibacterial effects of silver are well established. Now, researchers at Yonsei University in Seoul, Republic of Korea, have developed a technique to coat glass with a layer of silver ions that can prevent growth of pathogenic bacteria including Escherichia coli, Salmonella typhimurium and Campylobacter jejuni. The technology could be used to protect medical equipment.

Advertisement

New Clinical Study Launches to Evaluate Healing of Knee Cartilage Using a Patient’s Own Regenerative Cells

June 26, 2013 6:00 am | by Business Wire | News | Comments

InGeneron, Inc., an innovator in cell-based technologies for healthcare and veterinary medicine, announced today a study to assess the use of adult adipose derived regenerative cells to enhance cartilage healing after knee surgery. The study will utilize InGeneron’s patented Transpose RT system to prepare regenerative cells from the patient’s own fat tissue.

PMA Final Decisions for April 2013

June 26, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

These are Premarket Approvals (PMA), Product Development Protocols (PDP), Supplement and Notice Decisions. This list is generated on a monthly basis. A PDF document that contains the "Approval letter and Summary of Safety and Effectiveness" is being added to this listing for each PMA. The PMA number will appear as a link if this document is available.

MEDICA Conferences & Forums

June 21, 2013 1:50 pm | by Messe Düsseldorf | Events

The conference program for MEDICA 2013, International Trade Fair with Congress – World Forum for Medicine, is undergoing a full re-launch. The content repositioning for MEDICA 2013 (to be held from November 20 – 23, 2103 in Düsseldorf, Germany) is designed to closely fit the program of the trade fair’s topics relevant to medical equipment users and to expand the international side of the program.

Synergy Biomedical Launches BioSphere Putty, a Next Generation Bioactive Bone Graft

June 20, 2013 3:38 pm | by Business Wire | News | Comments

Synergy Biomedical, LLC has announced that it has recently received FDA clearance and will be launching its first bone graft product, BioSphere™ Putty. Utilizing a specialized form of 45S5 bioactive glass with a unique sphere shape and a narrow size range, BioSphere™ Putty provides an optimized bone graft material that outperforms other bioactive products.

Researchers Come to Grips with Seahorse Armor

June 20, 2013 9:21 am | by Reuters | Videos | Comments

Researchers are developing a new type of gripping arm for medical and engineering applications, using the the flexible armor of seahorses as a model. A team at the University of California San Diego says the creature's natural armor plating provides a degree of strength and flexibility that does not exist outside nature. Tara Cleary reports.

Advertisement

From Orthopedics to Power Transfer—A Bright Future for Implants

June 19, 2013 4:51 pm | by Kasey Panetta, Managing Editor, ECN | Articles | Comments

Much like other medical technology, implants are adapting to a post-depression economy brimming with new materials, new ideas, and ambitious plans for the future. The result is a focus on designing safer, more bio-compatible products for local markets.

The New CeSpaceXP Cervical Interbody System

June 19, 2013 9:48 am | by Aesculap Implant Systems | News | Comments

Aesculap Implant Systems recently introduced the CeSpaceXP Interbody System for ACDF procedures. The CeSpaceXP fuses two proven materials, an innovative Plasmapore®XP  osteoconductive porous Titanium coating and a PEEK-Optima® radiolucent core, that  delivers enhanced implant stability, artifact-free imaging, and an optimal scaffold for cervical fusion procedures.

Bioabsorbable Polymers Will Offer New Possibilities for Drug Delivery

June 14, 2013 3:14 pm | by Uwe Winzen, Ph.D., Global Marketing Manager, Lubrizol LifeScience Polymers | Articles | Comments

A new formulation of synthetic, biochemically absorbable polymers is creating opportunities in the medical device and pharmaceutical fields. These “bioabsorbable polymers” are materials designed to dissolve into compounds that the body can safely absorb or eliminate.

Fingernails Reveal Clues to Limb Regeneration

June 13, 2013 10:54 am | by NYU Langone Medical Center/New York University School of Medicine | News | Comments

Mammals possess the remarkable ability to regenerate a lost fingertip, including the nail, nerves and even bone. In humans, an amputated fingertip can sprout back in as little as two months, a phenomenon that has remained poorly understood until now. In a paper published today in the journal Nature, researchers at NYU Langone Medical Center shed light on this rare regenerative power in mammals.

The Pulse: New Interface Rewires Nerves from Amputated Limbs

June 13, 2013 9:43 am | by Eric Sorensen, Coordinator of Multimedia Development | Videos | Comments

On this episode of The Pulse, rewired nerves from amputated limbs allow for prosthetic control with existing muscles, a bioengineered blood vessel is transplanted, diabetes is diagnosed through breath analysis alone, and a new technology is paving the way for low-cost electronic devices that work in direct contact with living tissue inside the body.

Medtronic Announces CE Mark of Its ReDuX(TM) Plier Instrument, an Innovative Device to Perform Osteotomies in Spinal Deformity Surgeries

June 13, 2013 2:06 am | by The Associated Press | News | Comments

Medtronic, Inc. has announced the CE Mark and the European launch of the ReDuX Plier, a new instrument specially designed for use during osteotomies.  With the launch of this first specially-designed surgical instrument in the spinal orthopaedic industry, physicians in the European community may now perform a more controlled osteotomy closure for people with a severe form of spinal curvature.

Abyrx,T Inc. Receives FDA 510(k) Clearance for New Absorbable Hemostatic Bone Putty (AHBPT)

June 12, 2013 4:43 pm | by The Associated Press | News | Comments

  Abyrx, Inc., a privately-held therapeutic device company, today announced that the United States Food and Drug Administration has cleared its new Absorbable Hemostatic Bone Putty (AHBP) for clinical use in the United States. AHBP is provided ready-to-use (without requiring mixing or warming)...  

Study Assesses Impact of Rheumatoid Arthritis on Joint Replacement Surgery Outcomes

June 12, 2013 10:56 am | by Hospital for Special Surgery | News | Comments

Two new studies by researchers at Hospital for Special Surgery have shed light on joint replacement outcomes in patients with rheumatoid arthritis (RA). One study overturns the common belief that RA patients have worse outcomes after a total knee replacement (TKR) than patients who undergo the operation for osteoarthritis.

Nerve Interface for Direct Sensory Feedback

June 12, 2013 10:33 am | by DARPA | Videos | Comments

Researchers at Case Western Reserve University used a flat interface nerve electrode (FINE) to demonstrate direct sensory feedback. By interfacing with residual nerves in the patient's partial limb, some sense of touch by the fingers is restored. Other existing prosthetic limb control systems rely solely on visual feedback.

Targeted Muscle Re-innveration for Advanced Prosthetic Control

June 12, 2013 10:26 am | by DARPA | Videos | Comments

A team of researchers at the Rehabilitation Institute of Chicago (RIC) demonstrated a type of peripheral interface called targeted muscle re-innervation (TMR). By rewiring nerves from amputated limbs, new interfaces allow for prosthetic control with existing muscles. Former Army Staff Sgt. Glen Lehman, injured in Iraq, recently demonstrated improved TMR technology.

New Nerve and Muscle Interfaces Aid Wounded Warrior Amputees

June 12, 2013 10:18 am | by DARPA | News | Comments

Since 2000, more than 2,000 servicemembers have suffered amputated limbs. DARPA’s breakthrough research with advanced prosthetic limbs controlled by brain interfaces is well documented, but such research is currently limited to quadriplegics; practical applications of brain interfaces for amputees are still in the future. In contrast, nerve and muscle interfaces allow amputees to control advanced prosthetics in the near term.

RTI Biologics Announces Agreement to Acquire Pioneer Surgical Technology

June 12, 2013 7:00 am | by Business Wire | News | Comments

RTI Biologics Inc., a leading provider of orthopedic and other biologic implants, announced today its intent to acquire privately held Pioneer® Surgical Technology (Pioneer), headquartered in Marquette, Mich. Pioneer is a leading medical technology company that manufactures and distributes metal and synthetic products in the orthopedics, biologics, spine, trauma and cardiothoracic markets.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading